Management of varicella-zoster virus infections in children.
The introduction of varicella vaccine for immunization of healthy children is expected to have a gradual impact on the incidence of VZV infections in the population but antiviral therapy remains an important intervention in clinical practice. The efficacy of aciclovir for treatment of primary and recurrent VZV infections in children has reduced the morbidity and mortality of these illnesses in immunocompromised children dramatically. Oral aciclovir is an effective and useful for the management of varicella in healthy children and adolescents.
Arvin
A M
AM
Department of Pediatrics, Stanford University School of Medicine, California 94305, USA.
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002644:Chickenpox / Q000188:drug therapy* / Q000517:prevention & control*; D019433:Chickenpox Vaccine; D002648:Child; D006562:Herpes Zoster / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D016867:Immunocompromised Host
D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D000212:Acyclovir